Home › Attention Deficit Hyperactivity Disorder › Maryland › Baltimore
Attention Deficit Hyperactivity Disorder clinical trials in Baltimore, MD
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Kennedy Krieger Institute, Baltimore
Medication Treatment of ADHD in Pediatric Epilepsy
RecruitingPhase 4
- Kennedy Krieger Institute, Baltimore
Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD
RecruitingHealthy volunteers welcome
- Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore
- Kennedy Krieger Institute, Baltimore
The Myelin Disorders Biorepository Project
RecruitingObservational study
- Kennedy Krieger Institute, Baltimore
About Attention Deficit Hyperactivity Disorder
Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Philadelphia, PA6 studies
- Austin, TX6 studies
- Pittsburgh, PA5 studies
- Washington, DC5 studies
- Orlando, FL5 studies
- Las Vegas, NV5 studies
- Los Angeles, CA4 studies
- Atlanta, GA4 studies
- New York City, NY4 studies
- Durham, NC4 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Cancer (all types)38 studies
- Pancreatic Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.